Argente J, Caballo N, Barrios V, Muñoz M T, Pozo J, Chowen J A, Morandé G, Hernández M
Department of Pediatrics, Autonomous University, Madrid, Spain.
J Clin Endocrinol Metab. 1997 Jul;82(7):2084-92. doi: 10.1210/jcem.82.7.4090.
We have studied the GH-insulin-like growth factor (IGF) axis in patients with anorexia nervosa at the time of diagnosis and at two points during weight recuperation. We report their spontaneous GH secretion and IGF-I, free IGF-I (fIGF-I), IGF-II, the IGF-binding proteins (IGFBP-1, IGFBP-2, and IGFBP-3), and GH-binding protein (GHBP) levels at the time of the clinical diagnosis (n = 50) and after recuperation of between 6-8% (n = 42) and 10% or less of the initial weight (n = 20). Two distinct groups were seen, those who significantly hypersecreted GH and those whose GH secretion was reduced significantly. After recuperation of 10% or more of their initial weight, all patients had a normal GH pattern. Independently of GH secretory dynamics, IGF-1, IGFBP-3, and GHBP serum levels were all significantly decreased at diagnosis, and only GHBP returned to normal after weight recuperation. Serum IGFBP-1 and IGFBP-2 levels were significantly increased at the time of diagnosis and decreased after weight recuperation. The body mass index (BMI) correlated positively with fIGF-I levels and negatively with IGFBP-1 and IGFBP-2 levels, but only after weight recuperation in all cases. Contrary to what is seen in normal individuals, no correlation was found between BMI and serum GHBP levels in anorexia nervosa patients. Serum IGFBP-2 levels had a strong negative correlation with fIGF-I, IGF-II, and the sum of IGF-I and IGF-II, but only at the time of diagnosis. In conclusion, the GH-IGF axis is dramatically altered in patients with anorexia nervosa. Changes in the peripheral IGF system however, appear to be independent of modifications in GH secretion and, in contrast to current thought, not all of the observed abnormalities are rapidly reversed with weight recuperation.
我们研究了神经性厌食症患者在诊断时以及体重恢复过程中的两个时间点的生长激素-胰岛素样生长因子(IGF)轴。我们报告了他们在临床诊断时(n = 50)以及体重恢复6 - 8%(n = 42)和初始体重恢复10%或更低时(n = 20)的自发性生长激素分泌以及IGF-I、游离IGF-I(fIGF-I)、IGF-II、IGF结合蛋白(IGFBP-1、IGFBP-2和IGFBP-3)和生长激素结合蛋白(GHBP)水平。观察到两个不同的组,即生长激素分泌显著过多的患者和生长激素分泌显著减少的患者。在恢复到初始体重的10%或更多后,所有患者的生长激素模式均正常。无论生长激素分泌动态如何,IGF-1、IGFBP-3和GHBP血清水平在诊断时均显著降低,只有GHBP在体重恢复后恢复正常。血清IGFBP-1和IGFBP-2水平在诊断时显著升高,在体重恢复后降低。体重指数(BMI)与fIGF-I水平呈正相关,与IGFBP-1和IGFBP-2水平呈负相关,但仅在所有病例体重恢复后如此。与正常个体不同,神经性厌食症患者的BMI与血清GHBP水平之间未发现相关性。血清IGFBP-2水平与fIGF-I、IGF-II以及IGF-I和IGF-II之和呈强烈负相关,但仅在诊断时如此。总之,神经性厌食症患者的生长激素-IGF轴发生了显著改变。然而,外周IGF系统的变化似乎独立于生长激素分泌的改变,并且与当前观点相反,并非所有观察到的异常都会随着体重恢复而迅速逆转。